×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KRON – kronos bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KRON
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/28
12:02 pm
kron
Kronos Bio announces interim CEO and workforce cuts of 83% [Yahoo! Finance]
Low
Report
Kronos Bio announces interim CEO and workforce cuts of 83% [Yahoo! Finance]
11/27
09:05 am
kron
Kronos Bio Shakes Up Leadership - Cuts 83% Of Workforce Amid Strategic Overhaul [Yahoo! Finance]
Low
Report
Kronos Bio Shakes Up Leadership - Cuts 83% Of Workforce Amid Strategic Overhaul [Yahoo! Finance]
11/27
07:30 am
kron
Kronos Bio Announces CEO Transition and Reduction in Force
Medium
Report
Kronos Bio Announces CEO Transition and Reduction in Force
11/16
07:42 am
kron
Kronos Bio Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
Kronos Bio Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/14
04:07 pm
kron
Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024 [Yahoo! Finance]
Low
Report
Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024 [Yahoo! Finance]
11/14
04:02 pm
kron
Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024
Low
Report
Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024
11/14
08:09 am
kron
Kronos Bio, Inc. (NASDAQ: KRON) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating.
Medium
Report
Kronos Bio, Inc. (NASDAQ: KRON) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating.
11/14
08:09 am
kron
Kronos Bio, Inc. (NASDAQ: KRON) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $1.00 price target on the stock, down previously from $6.00.
Medium
Report
Kronos Bio, Inc. (NASDAQ: KRON) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $1.00 price target on the stock, down previously from $6.00.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/27
06:01 am
kron
Form 8-K Kronos Bio, Inc. For: Nov 22
High
Report
Form 8-K Kronos Bio, Inc. For: Nov 22
11/14
07:58 am
kron
Form SC 13G/A Kronos Bio, Inc. Filed by: Omega Fund V, L.P.
Medium
Report
Form SC 13G/A Kronos Bio, Inc. Filed by: Omega Fund V, L.P.
11/13
04:11 pm
kron
Form 10-Q Kronos Bio, Inc. For: Sep 30
Medium
Report
Form 10-Q Kronos Bio, Inc. For: Sep 30
11/13
04:07 pm
kron
Form 8-K Kronos Bio, Inc. For: Nov 13
Medium
Report
Form 8-K Kronos Bio, Inc. For: Nov 13
11/7
05:03 pm
kron
Form 8-K Kronos Bio, Inc. For: Nov 04
Medium
Report
Form 8-K Kronos Bio, Inc. For: Nov 04
10/15
06:57 pm
kron
Form 4 Kronos Bio, Inc. For: Oct 15 Filed by: Frisbee Allison
Low
Report
Form 4 Kronos Bio, Inc. For: Oct 15 Filed by: Frisbee Allison
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: